SUPPLEMENT
Q1 2020 — Supplemental Sales Data
Q1 2020PDF · 2 pages24 KB
Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) 2020 2019 Total Operations Currency Sales to customers by segment of business Consumer Health U.S. 1,740 $ 1,438 21.0 % 21.0 - International 1,885 1,880 0.3 3.9 (3.6) 3,625 3,318 9.2 11.3 (2.1) Pharmaceutical U.S. 6,061 5,582 8.6 8.6 - International 5,073 4,662 8.8 12.0 (3.2) 11,134 10,244 8.7 10.1 (1.4) Medical Devices U.S. 2,898 3,109 (6.8) (6.8) - International 3,034 3,350 (9.4) (6.9) (2.5) 5,932 6,459 (8.2) (6.9) (1.3) U.S. 10,699 10,129 5.6 5.6 - International 9,992 9,892 1.0 4.0 (3.0) Worldwide 20,691 $ 20,021 3.3 % 4.8 (1.5) Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. FIRST QUARTER Percent Change -- 1 of 2 -- Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) 2020 2019 Total Operations Currency Sales to customers by geographic area U.S. 10,699 $ 10,129 5.6 % 5.6 - Europe 4,827 4,609 4.7 7.5 (2.8) Western Hemisphere excluding U.S. 1,502 1,503 (0.1) 8.5 (8.6) Asia-Pacific, Africa 3,663 3,780 (3.1) (1.9) (1.2) International 9,992 9,892 1.0 4.0 (3.0) Worldwide 20,691 $ 20,021 3.3 % 4.8 (1.5) Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. FIRST QUARTER Percent Change -- 2 of 2 --